GAIA BioMedicine

GAIA BioMedicine

Developing a new platform to generate nk-like cells that can effectively eliminate solid tumors without the need for genetic modification.

Launch date
Employees
Market cap
-
Enterprise valuation
$6—9m (Dealroom.co estimates Nov 2020.)
Fukuoka Fukuoka Prefecture (HQ)
Authorizing premium user...